A detailed history of Jw Asset Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Jw Asset Management, LLC holds 2,292,418 shares of HRTX stock, worth $2.57 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
2,292,418
Previous 2,292,418 -0.0%
Holding current value
$2.57 Million
Previous $8.02 Million 43.15%
% of portfolio
2.06%
Previous 3.31%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$0.54 - $1.82 $62,100 - $209,300
-115,000 Reduced 4.78%
2,292,418 $3.9 Million
Q3 2023

Nov 09, 2023

BUY
$0.97 - $1.8 $194,000 - $360,000
200,000 Added 9.06%
2,407,418 $2.48 Million
Q2 2023

Aug 11, 2023

BUY
$1.11 - $2.88 $2.45 Million - $6.36 Million
2,207,418 New
2,207,418 $2.56 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $133M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Jw Asset Management, LLC Portfolio

Follow Jw Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jw Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jw Asset Management, LLC with notifications on news.